This company has been marked as potentially delisted and may not be actively trading. Cyanotech (CYAN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesInsider TradesShort InterestTrendsBuy This Stock CYAN vs. HAPP, BON, SMFL, CSCI, KPRX, POAI, PCSA, DWTX, MTNB, and APREShould you be buying Cyanotech stock or one of its competitors? The main competitors of Cyanotech include Happiness Development Group (HAPP), Bon Natural Life (BON), Smart for Life (SMFL), COSCIENS Biopharma (CSCI), Kiora Pharmaceuticals (KPRX), Predictive Oncology (POAI), Heatwurx (PCSA), Dogwood Therapeutics (DWTX), Matinas Biopharma (MTNB), and Aprea Therapeutics (APRE). Cyanotech vs. Its Competitors Happiness Development Group Bon Natural Life Smart for Life COSCIENS Biopharma Kiora Pharmaceuticals Predictive Oncology Heatwurx Dogwood Therapeutics Matinas Biopharma Aprea Therapeutics Happiness Development Group (NASDAQ:HAPP) and Cyanotech (NASDAQ:CYAN) are both small-cap medicinals & botanicals industry companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings. Do institutionals & insiders have more ownership in HAPP or CYAN? 15.2% of Happiness Development Group shares are held by institutional investors. Comparatively, 24.4% of Cyanotech shares are held by institutional investors. 15.6% of Happiness Development Group shares are held by company insiders. Comparatively, 29.1% of Cyanotech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more risk & volatility, HAPP or CYAN? Happiness Development Group has a beta of 0.23, indicating that its stock price is 77% less volatile than the S&P 500. Comparatively, Cyanotech has a beta of -0.11, indicating that its stock price is 111% less volatile than the S&P 500. Does the media refer more to HAPP or CYAN? In the previous week, Happiness Development Group's average media sentiment score of 0.00 equaled Cyanotech'saverage media sentiment score. Company Overall Sentiment Happiness Development Group Neutral Cyanotech Neutral Is HAPP or CYAN more profitable? Happiness Development Group has a net margin of 0.00% compared to Cyanotech's net margin of -19.50%. Happiness Development Group's return on equity of 0.00% beat Cyanotech's return on equity.Company Net Margins Return on Equity Return on Assets Happiness Development GroupN/A N/A N/A Cyanotech -19.50%-44.71%-19.12% Which has higher earnings and valuation, HAPP or CYAN? Cyanotech has lower revenue, but higher earnings than Happiness Development Group. Cyanotech is trading at a lower price-to-earnings ratio than Happiness Development Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHappiness Development Group$95.59M0.06-$49.19M$0.481.60Cyanotech$23.07M0.09-$5.27M-$0.66-0.42 SummaryHappiness Development Group beats Cyanotech on 7 of the 11 factors compared between the two stocks. Get Cyanotech News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYAN vs. The Competition Export to ExcelMetricCyanotechMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.97M$3.54B$5.80B$10.17BDividend YieldN/AN/A5.73%4.61%P/E Ratio-0.429.4874.8626.39Price / Sales0.0979.38544.60190.76Price / CashN/A5.6225.8129.91Price / Book0.211.1513.256.28Net Income-$5.27M$17.44M$3.29B$270.38M Cyanotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYANCyanotech0.4388 of 5 stars$0.28-6.0%N/A-57.9%$1.97M$23.07M-0.4295Gap DownHAPPHappiness Development GroupN/A$0.72+3.8%N/A-13.8%$4.98M$95.59M1.49215Gap UpBONBon Natural LifeN/A$1.48+5.0%N/A-95.8%$247K$23.84M0.00100Gap UpSMFLSmart for LifeN/A$0.00+100.0%N/A-99.9%$16K$11.11M0.00110Gap UpCSCICOSCIENS BiopharmaN/A$3.08+1.3%N/A-37.3%$9.65M$9.59M-0.5120Positive NewsKPRXKiora Pharmaceuticals2.6065 of 5 stars$2.73-1.8%$10.00+266.3%-28.7%$9.55M$16.02M-0.9410Positive NewsShort Interest ↑POAIPredictive Oncology1.3014 of 5 stars$0.91+3.7%N/A+3.7%$9.53M$1.62M-0.3030Positive NewsShort Interest ↓PCSAHeatwurx3.6907 of 5 stars$0.19-0.5%$1.00+431.6%-85.0%$9.52MN/A-0.0820DWTXDogwood Therapeutics2.0974 of 5 stars$4.89-1.3%$10.00+104.3%N/A$9.48MN/A-0.265Positive NewsMTNBMatinas Biopharma0.0815 of 5 stars$1.83+0.5%N/AN/A$9.31MN/A-0.3830Short Interest ↑APREAprea Therapeutics2.7818 of 5 stars$1.57+0.3%$15.50+887.3%-52.1%$9.12M$1.50M-0.687Short Interest ↑ Related Companies and Tools Related Companies HAPP Competitors BON Competitors SMFL Competitors CSCI Competitors KPRX Competitors POAI Competitors PCSA Competitors DWTX Competitors MTNB Competitors APRE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYAN) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyanotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyanotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
